Illness perception and symptom burden among cancer patients: cross-sectional study.
단면연구
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
chemotherapy
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
These findings emphasise the need for personalised psychosocial interventions and educational strategies. Tailored approaches are essential to improve coping and treatment adherence.
[OBJECTIVES] This study aimed to assess illness perception and symptom burden in cancer patients, focusing on how demographic and clinical factors influence these perceptions.
- p-value p=0.03
- p-value p=0.04
- 연구 설계 cross-sectional
APA
Ben Kridis W, Sakka D, Khanfir A (2026). Illness perception and symptom burden among cancer patients: cross-sectional study.. BMJ supportive & palliative care. https://doi.org/10.1136/spcare-2025-005998
MLA
Ben Kridis W, et al.. "Illness perception and symptom burden among cancer patients: cross-sectional study.." BMJ supportive & palliative care, 2026.
PMID
41708302
Abstract
[OBJECTIVES] This study aimed to assess illness perception and symptom burden in cancer patients, focusing on how demographic and clinical factors influence these perceptions.
[METHODS] A cross-sectional study was conducted with 102 cancer patients aged 18 years or older. Participants were assessed using the Brief Illness Perception Questionnaire (BIPQ) to measure illness perception, alongside sociodemographic data. Statistical analyses were performed to identify associations with gender, age, cancer stage and cancer type.
[RESULTS] The sample consisted of 68 women (67%) and 34 men (33%), with a mean age of 46 years. Half of the patients were between 40 and 60 years of age. Metastatic cancer was the most common stage (61%), and 100% received chemotherapy. A significant proportion of women (35%) reported high or very high perceptions of their illness compared with 2% of men (p=0.03). Patients aged 40-60 years and those with metastatic cancer also reported higher illness perceptions (p=0.04 and p=0.05). Breast cancer patients had the highest perception scores across all domains (p=0.01).
[CONCLUSION] Illness perception varies by gender, age, cancer stage and type. These findings emphasise the need for personalised psychosocial interventions and educational strategies. Tailored approaches are essential to improve coping and treatment adherence.
[METHODS] A cross-sectional study was conducted with 102 cancer patients aged 18 years or older. Participants were assessed using the Brief Illness Perception Questionnaire (BIPQ) to measure illness perception, alongside sociodemographic data. Statistical analyses were performed to identify associations with gender, age, cancer stage and cancer type.
[RESULTS] The sample consisted of 68 women (67%) and 34 men (33%), with a mean age of 46 years. Half of the patients were between 40 and 60 years of age. Metastatic cancer was the most common stage (61%), and 100% received chemotherapy. A significant proportion of women (35%) reported high or very high perceptions of their illness compared with 2% of men (p=0.03). Patients aged 40-60 years and those with metastatic cancer also reported higher illness perceptions (p=0.04 and p=0.05). Breast cancer patients had the highest perception scores across all domains (p=0.01).
[CONCLUSION] Illness perception varies by gender, age, cancer stage and type. These findings emphasise the need for personalised psychosocial interventions and educational strategies. Tailored approaches are essential to improve coping and treatment adherence.
같은 제1저자의 인용 많은 논문 (4)
- First-Line Anti-PD-1 Immunotherapy With Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: A Meta-Analysis by PD-1 Subtype.
- Efficacy and safety of adjuvant capecitabine and pembrolizumab in early-stage triple-negative breast cancer after standard neo-/adjuvant chemotherapy: A meta-analysis of phase III studies.
- Adjuvant PD-1 Inhibitors After Radical Surgery for High-Risk Muscle-Invasive Urothelial Carcinoma: A Systematic Review and Meta-Analysis of Phase 3 Trials.
- Diet and Physical Activity Interventions to Improve Outcomes in Colorectal Cancer Survivors: A Multicenter Randomized Controlled Trial in North Africa.